KEYWORDS:
Avelox; Chlamydophila pneumoniae; Haemophilus influenzae; Levaquin; Mycoplasma pneumoniae; Nuzyra; Pseudomonas aeruginosa; Streptococcus pneumoniae; Xenleta; adverse effects; amoxicillin; ampicillin/sulbactam; azithromycin; cefotaxime; cefpodoxime; ceftaroline; ceftriaxone; dosage; doxycycline; drug interactions; efficacy; fluoroquinolones; lactation; lefamulin; levofloxacin ; linezolid; methicillin-resistant staphylococcus aureus; moxifloxacin; omadacycline; pregnancy; safety; vancomycin